<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57">
 <label>57.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Masuda</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Lefevre</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Mendelman</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Sherwood</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Bizjajeva</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Borkowski</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Immunogenicity of takeda's bivalent virus-like particle (VLP) norovirus vaccine (NoV) candidate in children from 6 months up to 4 years of age</article-title>. 
  <source>Open Forum Infect Dis.</source> (
  <year>2018</year>) 
  <volume>5</volume>(
  <issue>Suppl. 1</issue>):
  <fpage>S674</fpage>
  <pub-id pub-id-type="doi">10.1093/ofid/ofy210.1929</pub-id>
 </mixed-citation>
</ref>
